dsm-firmenich repurchased 385,000 of its own shares during the period from September 7, 2026 up to and including September 11, 2026, at an average price of €92.07 per share for a total amount of €35.4 million. The purchases are part of a repurchase program the company announced on February 9, 2026, covering ordinary shares with an aggregate market value of €500 million to reduce its issued capital, and which it began executing on March 12, 2026 for a total of €540 million. That €540 million total comprises €40 million to cover commitments under the Group's share-based compensation plans and €500 million to reduce issued capital. The €40 million portion earmarked for share-based compensation plans was finalized on March 23, 2026, while the €500 million capital-reduction program is intended to be completed by the end of Q3 2026. To date, 6,402,212 shares have been repurchased under the program at an average price of €72.91, for a total consideration of €466.8 million.
DSM-Firmenich AGdsm-firmenich repurchased 385,000 of its own shares for €35.4 million as part of its €500 million capital-reduction buyback program.
